Evidence map›Paper›PMID 39108724›Full record

ArticleiScience2024

Cisplatin resistance-related transcriptome and methylome integration identifies

Qizhi Zhu, Meng Fu, Jian Qi, Ziming Xu, Yongguang Wang, Zhipeng Wang, Dan Wang, Jiajia Liu, Ruiping Du, Xin Wei and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Qizhi ZhuHefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.
Meng FuHefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.
Jian QiHefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.
Ziming XuUniversity of Science and Technology of China, Hefei, Anhui, P.R. China.
Yongguang WangHefei Cancer Hospital of CAS, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.
Zhipeng WangHefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.
Dan WangUniversity of Science and Technology of China, Hefei, Anhui, P.R. China.
Jiajia LiuUniversity of Science and Technology of China, Hefei, Anhui, P.R. China.
Ruiping DuHefei Cancer Hospital of CAS, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.
Xin WeiHefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.
Hongzhi WangHefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.
Jinfu NieHefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.
Bo HongHefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.
Weiping XuHefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platinum-based chemo-resistance is the major issue for the treatment of small cell lung cancer (SCLC). The integrative analysis of multi-omics data is a reliable approach for discovering novel biomarkers associated with chemo-resistance. Here, multi-omics integrative analysis and Cox regression found that higher expression of

Indexed as

cancercancer systems biologytranscriptomics

Identifiers

PMID39108724
PMCPMC11301104

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.